Search
Verucerfont
go.drugbank.com/drugs/DB12512InvestigationalVerucerfont has been used in trials studying the treatment of Congenital Adrenal Hyperplasia.
Tedatioxetine
go.drugbank.com/drugs/DB12641InvestigationalTedatioxetine has been used in trials studying the treatment of Major Depressive Disorder.
Olumacostat glasaretil
go.drugbank.com/drugs/DB12642InvestigationalOlumacostat glasaretil has been used in trials studying the treatment of Acne Vulgaris.
Ozagrel
go.drugbank.com/drugs/DB12017InvestigationalOzagrel has been used in trials studying the treatment of Dry Eye Syndromes.
Sodium tripolyphosphate
go.drugbank.com/drugs/DB11493InvestigationalVet approvedIt is used as a component of a wide range domestic and industrial products, particularly detergents. … Sodium tripolyphosphate is an inorganic compound with formula Na5P3O10 and the sodium salt of the polyphosphate penta-anion.
Ficlatuzumab
go.drugbank.com/drugs/DB11680InvestigationalFiclatuzumab has been used in trials studying the treatment of Acute Myeloid Leukemia, Non-small Cell Lung Cancer, Mullerian Mixed Tumor of Ovary, Relapsed Acute Myeloid Leukemia, and Refractory Acute
Trestolone acetate
go.drugbank.com/drugs/DB13958ExperimentalIt is an androgen ester – specifically, the C17 acetate ester of [DB05830]. … Trestolone acetate is a synthetic and injected anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was never marketed.
Lavamilast
go.drugbank.com/drugs/DB19767ExperimentalThe usage of the INN stem '-milast' in the name indicates that Lavamilast is a Phosphodiesterase-4 (PDE4) inhibitor. Lavamilast has a monoisotopic molecular weight of 520.16 Da.
Minesapride
go.drugbank.com/drugs/DB20801ExperimentalThe usage of the INN stem '-pride' in the name indicates that Minesapride is a sulpiride derivative and analogue. Minesapride has a monoisotopic molecular weight of 454.2 Da.
Enzaplatovir
go.drugbank.com/drugs/DB21042ExperimentalThe usage of the INN stem '-atovir' in the name indicates that Enzaplatovir is a RSV fusion protein inhibitor. Enzaplatovir has a monoisotopic molecular weight of 377.15 Da.